Fig. 4: Cross-reactive antibody and B-cell responses to Omicron XBB after bivalent booster vaccination. | npj Vaccines

Fig. 4: Cross-reactive antibody and B-cell responses to Omicron XBB after bivalent booster vaccination.

From: Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens

Fig. 4

A IgG endpoint titres and (B) live virus IC50 titres against XBB spike. The dotted line indicates the limit of detection. Geometric mean titres (GMT) and geometric mean ratios (GMR) are shown above the graph. Asterisk indicates p value of Kruskal–Wallis test with Dunn’s post-test comparing D0 with D7, 14, 28 or 84. C Representative staining of XBB.1.5 spike probe among populations of AN+, AN+BA.1+ or AN-BA.1− IgG+ memory B cells. D Proportion of XBB+ cells in Ag+ IgG+ B cells at baseline and day 28 post-vaccination. Bold lines join the median for each time point. N = 32 at days 0 and 14; N = 31 at day 28 and N = 17 at day 84. B-cell proportions were analysed using a non-parametric paired-sample Wilcoxon signed-rank test. E Correlation between frequencies of BA.1-specific AIM+ CD4+ Tmem or F frequencies of AN+BA.1+XBB.1.5+ cross-reactive MBC at D0 and neutralisation titres against XBB at D28 post-vaccination (n = 31). Correlation assessed by Spearman r test. **p < 0.01, ***p < 0.001, ****p < 0.0001.

Back to article page